Cite
APA Citation
Vandenberghe, R., Riviere, M., Caputo, A., Sovago, J., Maguire, R. P., Farlow, M., Marotta, G., Sanchez‐Valle, R., Scheltens, P., Ryan, J. M., & Graf, A. (2017). active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study. Alzheimer's & dementia, 3(1), 10–22. http://access.bl.uk/ark:/81055/vdc_100102727875.0x000003